期刊文献+

792例食管癌三维技术放疗的疗效分析 被引量:58

Treatment outcomes of 792 cases of esophageal carcinoma patients treated with three-dimensionalradiotherapy
原文传递
导出
摘要 目的观察食管鳞状细胞癌三维技术放疗的局部控制率及生存率,并探讨影响因素。方法回顾分析2003-20HD8年收治的食管癌患者792例,采用三维适形放疗(672例)及调强放疗(120例)技术,1.8~2.0Gy/次,5次/周,处方剂量50~70Gy。同期放化疗142例,单纯放疗650例。Kaplan-Meier法计算局部控制率和生存率,幻卯以法单因素预后分析,Cox法多因素预后分析。结果随访率为95.8%,随访时间满5年者133例。全组1、3、5年局部控制率分别为76.6%、53.2%、48.6%,总生存率分别为70.1%、36.7%、28.0%。单因素预后分析显示T分期、N分期、临床分期、肿瘤体积为影响生存的因素(x^2=20.58~55.60,P均=0.000),多因素预后分析显示N分期、肿瘤体积为影响生存的因素(X。=6.35、29.23,P=0.012、0.000)。同期放化疗与单纯放疗的5年局部控制率分别为57.0%和46.8%(x^2=7.34,P=0.007),5年总生存率分别为32.8%和27.6%(x^2=3.42,P=0.064)。结论三维技术放疗食管癌的远期疗效较二维技术放疗明显提高。T分期、N分期、TNM分期、肿瘤体积是长期生存影响因素。加入同期化疗可提高患者的局部控制率。 Objective To investigate the long term clinical result of three-dimensional radiotherapy for esophageal carcinoma , discuss the effect of correlative factors to survival and local control . Methods From July 2003 to December 2008, 792 patients with esophageal cancer were eligible. Patients were treated with three-dimensional radiotherapy (672 patients) or intensity-modulated ( 120 patients) radiotherapy. The radiotherapy was delivered in 1.8 - 2. 0 Gy per fraction, 5 fractions per week, total dose of 50 - 70 Gy, (median, 60 Gy). 142 patients were treated by concurrent radiochemotherapy, and the other 650 patients radiotherapy alone. The local control rate and survival rate were calculated by Kaplan-Meier method. Logrank method was used for univariatc analyses. Cox regression model was used for multivariate analyses. Results The follow-up rate was 95.8%. The number of patients with 5 years time followed-up was 133. The l-year, 3-year and 5-year local control rates were 76. 6% , 53.2% , 48.6% , and the 1-year, 3-year and 5- year overall survival rates were 70. 1% , 36. 7% and 28. 0% , respectively. There were significant influence on the prognosis of T stage, N stage, TNM stage, tumor volume ( X^2 = 20. 58- 55.60, all P = 0. 000). The Cox multivariate model showed that N stage and tumor volume were independent prognostic factors (X^2 = 6. 35,29.23, P = 0. 012, O. 000). For the two groups of concurrent chemo-radiotherapy and radiotherapy alone, 5-year local control rates were 57. 0% and 46. 8% (X^2 = 7. 34, P = 0. 007 ) , the 5-year overall survival rate 32. 8% and 27. 6% ( X2 = 3.42, P = 0. 064. Conclusions Three-dimensional radiotherapy is effective for esophageal carcinoma. It might improve the local control rate and overall survival rate to some extent. T staging, N staging, TNM staging and tumor volume were important prognostic factors for long-term survival. The addition of concurrent radiochemotherapy could improve local control rates.
机构地区 石家庄
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2012年第5期421-424,共4页 Chinese Journal of Radiation Oncology
基金 河北省强势特色学科课题资助(冀教高[2005]52号)
关键词 食管肿瘤/三维放射疗法 三维放射疗法 适形 三维放射疗法 调强 预后 Esophageal neoplasms/three-dimensional radiotherapy Three-dimensionalradiotherapy, conformal Three-dimensional radiotherapy, intensity-modulated Prognosis
  • 相关文献

参考文献4

二级参考文献25

  • 1祝淑钗,李任,李娟,邱嵘,韩春,万钧.非手术治疗胸段食管癌临床分期与预后关系的初步探讨[J].中华放射肿瘤学杂志,2004,13(3):189-192. 被引量:70
  • 2刘俊,吕长兴,王家明.同步放化疗治疗不能手术的食管癌临床结果[J].中华放射肿瘤学杂志,2006,15(3):185-187. 被引量:90
  • 3万钧.食管癌放疗后复发的再治疗[M]//万钧,韩春,刘惠明.食管癌的放射治疗.2版.北京:原子能出版社,2006:157-160.
  • 4Thompson WM,Halvorsen RA,Foster WL Jr,et al.Computed tomography for staging esophageal and gastroesophageal cancer:reevaluation.AJR Am J Roentgenol,1983,141:951-958.
  • 5Picus D,Balfe M,Koehler RE,et al.Computed tomagraphy in the staging of esophageal carcinoma.Radiology,1983,146:433-438.
  • 6刘泰福.现代放射肿瘤学.上海:上海医科大学出版社,2008.
  • 7Takashima S,Takeuchi N,Shiozaki H,et al.Carcinoma of the osophagus:CT vs MR imaging in determining resectability.AJR Am J Roentgenol,1991,156:297-302.
  • 8麻国新,万钧.早期食管癌的放射治疗//万钧,韩春,刘惠明.食管癌的放射治疗.2版.北京:原子能出版社,2006:161-166.
  • 9Herskovie A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with caner of esophagus[J].New England J Med,1992, 326(24):1593-1598.
  • 10Minsky B D, Pajak T F, Ginsberg R J, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase Ⅲ trial of combinedmodality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy[J].J Clin Oneol, 2002,20(5):1151- 1153.

共引文献382

同被引文献470

引证文献58

二级引证文献483

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部